Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citrate-containing dialysate versus acetate dialysate in maintenance hemodialysis
RBR-2z9xybPhase 4Recruiting
- Sponsor
- Universidade Federal Fluminense
- Start
- Jul 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of trisodium citrate, heparin and Sodium Acetate in chronic kidney disease (CKD) (2 arms), sponsored by Universidade Federal Fluminense. Started Jul 2011; status: recruiting.
02
Drugs
trisodium citrateheparinSodium Acetate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on RBR-2z9xyb.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2z9xyb.